Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 25, 2023 (Week 47)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 9,656 32,999 1,331,636 1,499,506
New England 149 1,650 37,614 47,790
Connecticut - 430 1,155 11,314
Maine 35 74 2,687 2,868
Massachusetts 11 687 25,664 25,717
New Hampshire 26 82 2,494 2,573
Rhode Island 63 694 4,432 4,153
Vermont 14 37 1,182 1,165
Middle Atlantic 1,711 4,186 177,724 174,521
New Jersey - 789 29,933 30,229
New York (excluding New York City) 517 1,032 37,895 36,236
New York City 481 1,497 60,370 58,237
Pennsylvania 713 1,231 49,526 49,819
East North Central 1,210 4,577 177,041 207,114
Illinois 36 1,811 47,246 64,435
Indiana 323 879 28,800 30,682
Michigan 191 881 30,028 39,010
Ohio 478 1,211 49,235 49,585
Wisconsin 182 562 21,732 23,402
West North Central 459 2,137 83,052 92,386
Iowa 80 333 12,223 13,385
Kansas 52 335 9,858 12,773
Minnesota - 497 18,945 20,144
Missouri 283 746 28,809 29,164
Nebraska - 246 6,910 8,785
North Dakota - 91 1,879 3,365
South Dakota 44 123 4,428 4,770
South Atlantic 2,294 7,719 290,355 334,748
Delaware - 227 5,095 4,649
District of Columbia 57 199 5,879 7,419
Florida 1,236 2,784 101,556 96,306
Georgia 367 1,550 52,740 66,165
Maryland U NC U 27,832
North Carolina 5 1,445 54,079 58,582
South Carolina 1 774 29,335 32,560
Virginia 624 976 37,751 37,159
West Virginia 4 115 3,920 4,076
East South Central 792 2,452 82,659 100,494
Alabama 439 972 30,769 28,243
Kentucky 299 546 15,268 16,501
Mississippi 54 487 16,372 21,137
Tennessee - 1,094 20,250 34,613
West South Central 317 4,837 179,217 210,130
Arkansas 101 435 15,550 16,340
Louisiana 188 876 32,443 33,102
Oklahoma 28 473 14,042 18,545
Texas - 3,191 117,182 142,143
Mountain 902 2,556 99,228 106,883
Arizona 343 872 36,402 37,234
Colorado 244 844 23,042 23,705
Idaho 54 144 5,195 5,419
Montana 25 92 3,013 3,778
Nevada 101 331 10,609 14,757
New Mexico 5 255 9,551 10,222
Utah 130 255 10,026 10,116
Wyoming - 50 1,390 1,652
Pacific 1,822 5,049 204,746 225,440
Alaska 51 121 3,713 4,840
California 1,317 4,112 169,623 175,172
Hawaii - 132 - 4,978
Oregon 252 382 13,763 14,238
Washington 202 565 17,647 26,212
U.S. Territories - 102 1,138 4,230
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 102 1,138 4,230
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 5 47 127
Total 9,657 33,085 1,332,821 1,503,863
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.